Literature DB >> 10102699

Marked resistance of the ability of insulin to decrease arterial stiffness characterizes human obesity.

J Westerbacka1, S Vehkavaara, R Bergholm, I Wilkinson, J Cockcroft, H Yki-Järvinen.   

Abstract

We tested the hypothesis that insulin has effects on large artery stiffness in addition to its slow vasodilatory effect on resistance vessels in skeletal muscle, and whether such an effect might be altered in obesity. Eight nonobese (aged 25 +/- 1 years, BMI 22.7 +/- 0.4 kg/m2) and eight obese (aged 27 +/- 2 years, BMI 30.6 +/- 0.9 kg/m2) men were studied under normoglycemic-hyperinsulinemic (sequential 2-h insulin infusions of 1 [step 1] and 2 [step 2] mU x kg(-1) x min(-1)) conditions, and another seven men participated in a saline control study. Central aortic pressure waves were synthesized from those recorded in the periphery using applanation tonometry and a validated reverse transfer function every 30 min. This allowed determination of augmentation (the pressure difference between early and late systolic pressure peaks) and the augmentation index (augmentation divided by pulse pressure), a measure of arterial stiffness. Whole-body glucose uptake was reduced by 48 (step 1) and 41% (step 2) (P < 0.01) in the obese subjects versus the nonobese subjects. Basal forearm blood flow averaged 2.5 +/- 0.2 and 2.6 +/- 0.2 ml x dl(-1) x min(-1) in the obese and nonobese subjects, respectively (NS). Insulin induced a significant increase in forearm blood flow after 2.5 h (3.6 +/- 0.4 ml x dl(-1) x min(-1), P < 0.05 vs. basal) in the nonobese subjects and after 4 h in the obese subjects (3.2 +/- 0.2, P < 0.05). In contrast to these slow changes in peripheral blood flow, augmentation and the augmentation index decreased significantly in the nonobese subjects after 1 h (-3.0 +/- 1.6 mmHg and -10.0 +/- 5.4%, respectively, P < 0.001 vs. basal), but remained unchanged until 3 h in the obese subjects. Percent fat (r = 0.86, P < 0.0001) and whole-body glucose uptake (r = -0.72, P < 0.01) correlated with the change in the augmentation index by insulin. These data demonstrate temporal dissociation in insulin's vascular actions. Insulin's effect to decrease arterial stiffness in nonobese subjects (a decrease in wave reflection) is observed under physiological conditions and precedes a slow vasodilatory effect in the periphery. In the obese subjects, insulin's normal effect to decrease central wave reflection is severely blunted. The degree of impairment in this novel vascular action of insulin is closely correlated with the degree of obesity and insulin action on glucose uptake.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10102699     DOI: 10.2337/diabetes.48.4.821

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  27 in total

1.  Progressive hyperglycemia across the glucose tolerance continuum in older obese adults is related to skeletal muscle capillarization and nitric oxide bioavailability.

Authors:  Thomas P J Solomon; Jacob M Haus; Yanjun Li; John P Kirwan
Journal:  J Clin Endocrinol Metab       Date:  2011-02-02       Impact factor: 5.958

Review 2.  Arterial compliance in obese children: implications for cardiovascular health.

Authors:  Jeanie B Tryggestad; Kevin R Short
Journal:  Exerc Sport Sci Rev       Date:  2014-10       Impact factor: 6.230

Review 3.  Isolated Systolic Hypertension in Young and Middle-Aged Adults.

Authors:  Yuichiro Yano; Donald M Lloyd-Jones
Journal:  Curr Hypertens Rep       Date:  2016-11       Impact factor: 5.369

4.  Insulin Enhances Endothelial Function Throughout the Arterial Tree in Healthy But Not Metabolic Syndrome Subjects.

Authors:  Linda A Jahn; Lee Hartline; Nagashree Rao; Brent Logan; Justin J Kim; Kevin Aylor; Li-Ming Gan; Helena U Westergren; Eugene J Barrett
Journal:  J Clin Endocrinol Metab       Date:  2016-01-12       Impact factor: 5.958

Review 5.  Insulin regulates its own delivery to skeletal muscle by feed-forward actions on the vasculature.

Authors:  Eugene J Barrett; Hong Wang; Charles T Upchurch; Zhenqi Liu
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-05-24       Impact factor: 4.310

6.  Antiobesogenic role of endothelial nitric oxide synthase.

Authors:  Brian E Sansbury; Bradford G Hill
Journal:  Vitam Horm       Date:  2014       Impact factor: 3.421

Review 7.  Insulin resistance, the metabolic syndrome, diabetes, and cardiovascular disease risk in women with PCOS.

Authors:  H J Teede; S Hutchison; S Zoungas; C Meyer
Journal:  Endocrine       Date:  2006-08       Impact factor: 3.633

Review 8.  Mechanisms of adverse cardiometabolic consequences of obesity.

Authors:  Carlos M Diaz-Melean; Virend K Somers; Juan Pablo Rodriguez-Escudero; Prachi Singh; Ondrej Sochor; Ernesto Manuel Llano; Francisco Lopez-Jimenez
Journal:  Curr Atheroscler Rep       Date:  2013-11       Impact factor: 5.113

Review 9.  Effects of exercise, diet and weight loss on high blood pressure.

Authors:  Simon L Bacon; Andrew Sherwood; Alan Hinderliter; James A Blumenthal
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

Review 10.  The IGF-1 receptor and regulation of nitric oxide bioavailability and insulin signalling in the endothelium.

Authors:  V Kate Gatenby; Helen Imrie; Mark Kearney
Journal:  Pflugers Arch       Date:  2013-01-22       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.